
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Merkel cell cancer other imaging findings
Introduction
Overview
Overview
Positron emission tomography (PET) imaging may be used for the staging of merkel cell cancer.
- Other Imaging Findings
![]() |
2-fluoro-D-2-deoxyglucose (FDG) Positron Emission Tomography
- Positron emission tomography (PET) may be helpful in the diagnosis of merkel cell cancer.
- PET helps with the following:[1][2][3]
- Staging
- Follow up
- Lymph nodes involvement
- Metastasis
- Responses to therapy
- Residual disease
Ultrasound
- Ultrasound may be helpful in the diagnosis of merkel cell cancer.
- Ultrasound helps with the following:[4][5]
- To assess lymphatic drainage
References
References
- ↑ Gollub MJ, Gruen DR, Dershaw DD (September 1996). “Merkel cell carcinoma: CT findings in 12 patients”. AJR Am J Roentgenol. 167 (3): 617–20. doi:10.2214/ajr.167.3.8751663.
- ↑ Golan H, Volkov O, Linchinsky O, Melloul M (2005). “FDG-PET imaging in Merkel cell carcinoma – value of head-to-toe scan”. Nucl Med Rev Cent East Eur. 8 (2): 135–6. PMID 16437401.
- ↑ Papavasiliou, Pavlos (2013). “Utility of PET/CT in the staging and treatment of patients with Merkel Cell Carcinoma and Melanoma”. Journal of Nuclear Medicine & Radiation Therapy. 04 (04). doi:10.4172/2155-9619.S5-001. ISSN 2155-9619.
- ↑ Schmerling RA, Casas JG, Cinat G, Ospina F, Kassuga L, Tlahuel J, Mazzuoccolo LD (July 2018). “Burden of Disease, Early Diagnosis, and Treatment of Merkel Cell Carcinoma in Latin America”. J Glob Oncol (4): 1–11. doi:10.1200/JGO.18.00041. PMID 30085832. Vancouver style error: initials (help)
- ↑ Enzenhofer, Elisabeth; Ubl, Philipp; Czerny, Christian; Erovic, Boban M. (2013). “Imaging in Patients with Merkel Cell Carcinoma”. Journal of Skin Cancer. 2013: 1–6. doi:10.1155/2013/973123. ISSN 2090-2905.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Â ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

